Large prospective cohorts should examine interactions between obesity-related genetic polymorphisms (e.g., CYP19A1, PTEN, PIK3CA), adipokine expression profiles, and metabolomic signatures to delineate high-risk phenotypes requiring intensified preventive surveillance. Here, CYP19A1 is linked to obesity disorder.